Drug
Albuterol Sulfate And Budesonide
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Device Delivery System Issue | 377 | 223.4 | 307.5 | signal |
| 2 | Device Use Issue | 117 | 103.8 | 113.4 | signal |
| 3 | Incorrect Dose Administered By Device | 114 | 68.8 | 74.9 | signal |
| 4 | Device Defective | 62 | 58.7 | 61.4 | signal |
| 5 | Wrong Technique In Device Usage Process | 150 | 50.2 | 56.3 | signal |
| 6 | Device Malfunction | 147 | 33.5 | 37.3 | signal |
| 7 | Asthma | 160 | 21.8 | 24.6 | signal |
| 8 | Drug Dose Omission By Device | 84 | 16.8 | 17.8 | signal |
| 9 | Seasonal Allergy | 14 | 15.1 | 15.3 | signal |
| 10 | Insurance Issue | 14 | 14.4 | 14.5 | signal |
| 11 | Drug Effect Less Than Expected | 13 | 14.1 | 14.2 | signal |
| 12 | Device Failure | 12 | 12.1 | 12.2 | signal |
| 13 | Product Dose Omission Issue | 220 | 11.8 | 13.9 | signal |
| 14 | Oral Candidiasis | 9 | 10.6 | 10.6 | signal |
| 15 | Wrong Technique In Product Usage Process | 132 | 10.0 | 10.9 | signal |
| 16 | Secretion Discharge | 8 | 9.9 | 9.9 | signal |
| 17 | Wheezing | 38 | 9.8 | 10.1 | signal |
| 18 | Impaired Quality Of Life | 9 | 9.5 | 9.6 | signal |
| 19 | Product Prescribing Issue | 12 | 9.0 | 9.1 | signal |
| 20 | Dysphonia | 34 | 8.9 | 9.1 | signal |
| 21 | Therapy Change | 5 | 7.9 | 7.9 | signal |
| 22 | Device Issue | 42 | 7.3 | 7.5 | signal |
| 23 | Infusion Site Pain | 6 | 7.2 | 7.2 | signal |
| 24 | Illness | 47 | 7.1 | 7.4 | signal |
| 25 | Decreased Activity | 5 | 7.1 | 7.1 | signal |
| 26 | Product Use Issue | 79 | 6.5 | 6.8 | signal |
| 27 | Incorrect Dose Administered | 88 | 6.0 | 6.3 | signal |
| 28 | Device Mechanical Issue | 5 | 5.9 | 5.9 | signal |
| 29 | Aphonia | 5 | 5.5 | 5.5 | signal |
| 30 | Product Packaging Issue | 3 | 4.9 | 4.9 | signal |
| 31 | Exposure Via Skin Contact | 7 | 4.7 | 4.7 | signal |
| 32 | Sleep Disorder Due To A General Medical Condition | 5 | 4.7 | 4.7 | signal |
| 33 | Device Occlusion | 4 | 4.4 | 4.4 | signal |
| 34 | Device Breakage | 11 | 4.3 | 4.3 | signal |
| 35 | Device Use Error | 9 | 4.0 | 4.1 | signal |
| 36 | Product Dose Omission In Error | 7 | 4.0 | 4.0 | signal |
| 37 | Injection Site Warmth | 5 | 3.7 | 3.7 | signal |
| 38 | Device Leakage | 9 | 3.2 | 3.3 | signal |
| 39 | Needle Issue | 6 | 3.2 | 3.2 | signal |
| 40 | Injection Site Swelling | 12 | 2.4 | 2.4 | signal |
| 41 | Therapeutic Response Shortened | 5 | 2.4 | 2.4 | no signal |
| 42 | Extra Dose Administered | 6 | 2.3 | 2.3 | no signal |
| 43 | Injection Site Pruritus | 9 | 2.1 | 2.1 | no signal |
| 44 | Injection Site Rash | 4 | 2.0 | 2.0 | no signal |
| 45 | Dermatitis Atopic | 5 | 1.5 | 1.5 | no signal |
| 46 | Accidental Exposure To Product | 9 | 1.4 | 1.4 | no signal |
| 47 | Device Difficult To Use | 5 | 1.2 | 1.2 | no signal |